Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Ten years ago

The role of endogenous opioids and monoamine neurotransmitters in non-suicidal self-injury

July 29, 2020

Leo Sher, M.D.

Our research work, “Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters” was published 10 years ago in the July 2010 issue of the Journal of Affective Disorders (1). The objective of the study was to examine the role of endogenous opioids and monoamine neurotransmitters in non-suicidal self-injury (NSSI).

We compared cerebrospinal fluid (CSF) levels of endogenous opioids, 5-hydroxyindolacetic acid (5-HIAA) and homovanillic acid (HVA) in individuals with a history of repeated NSSI with a diagnostically-matched group of people who had never engaged in non-suicidal self-injury (no NSSI). History of suicidal behavior, demographic parameters, and psychopathology was assessed. All patients were diagnosed with a Cluster B personality disorder (i.e., borderline, antisocial, narcissistic or histrionic) (N=29) and had a history of at least one suicide attempt. Fourteen participants had a history of repeated NSSI in adulthood and 15 did not. The mean age of the sample was 35.5 ± 9.1 (range 18-65). CSF samples were collected via lumbar puncture, and concentrations of β-endorphin, met-enkephalin, dynorphin, the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), and the dopamine metabolite, homovanillic acid (HVA), were determined for all participants.

The NSSI and no NSSI groups did not differ with respect to background characteristics: age, sex, ethnicity, marital status, religious affiliation, education level, or employment rate. Severity of depression, hopelessness and overall psychopathology was greater in the NSSI group. The NSSI group had significantly lower levels of CSF beta-endorphin and met-enkephalin when compared with the no NSSI group. CSF dynorphin, HVA and 5-HIAA levels did not differ.

Based on our findings, we proposed a model of non-suicidal self-injury. According to our model, opioid deficiency could result from chronic and severe childhood stress and trauma, such as abuse, neglect and loss or from a biological predisposition. Because endogenous opioids play a role in pain threshold and perception, they are likely candidates for involvement in NSSI, a behavior frequently associated with the need to feel pain or relieve emotional tension. Traumatized individuals may need increased levels of endorphins to cope with stress, and NSSI may be an effort at increasing the endogenous opioids to restore homeostasis.

If the endogenous opioid system is central to repetitive self-injury, then treatment with a long-acting opioid antagonist could block the reward of enhanced endogenous opioids caused by such behaviors and subsequently lead to their extinction. Therefore, drugs acting on the opioid system warrant exploration as pharmacological treatments for NSSI.

Reference

  1. Stanley B, Sher L, Wilson S, Ekman R, Huang YY, Mann JJ. Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord. 2010 Jul;124(1-2):134-40. doi: 10.1016/j.jad.2009.10.028. Epub 2009 Nov 25.

Related Posts

Ten years ago /

Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors

Ten years ago /

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

Ten years ago /

Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle

‹ Rates of suicide in 15-24-year-olds and per capita consumption of alcohol › Psychiatry and COVID-19

Editorials

  • Fluvoxamine attenuates COVID-19 disease
  • What? Botox injections can mitigate depressions?
  • Smoking, suicide risk, and the COVID-19 pandemic
  • Omicron spread and oral antiviral pills are big news. The advent of nirmatrelvir and ritonavir: called Paxlovid

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Thirty years of publications in the field of suicidology
  • Osteoporosis drugs are associated with depression and anxiety
  • A study of relation between the use of cannabis in adolescence and self-harm or suicide
  • Senior WISE intervention: Gender differences in bodily pain and trait anxiety

Latest News

  • Suicide mortality in the U.S. decreased from 2018 to 2020 after increasing since 2000
  • The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update
  • The Nobel Prize in Physiology or Medicine 2021
  • 2021 National Veteran Suicide Prevention Annual Report

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial
  • Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle
  • The role of endogenous opioids and monoamine neurotransmitters in non-suicidal self-injury

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.